NATURE’S SUNSHINE PRODUCTS, INC. Proceeds from Lines of Credit
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Proceeds from Lines of Credit of $30.93 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from lines of credit for the quarter ending 2026-06-30 was $19.31M, a 1675.18% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from lines of credit for the quarter ending 2026-03-31 was $11.62M, a 1481.09% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from lines of credit for the quarter ending 2025-12-31 was $3.26M, a 298.53% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from lines of credit for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from lines of credit for fiscal 2025 was $5.09M, a 87.59% decline from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from lines of credit for fiscal 2024 was $40.99M, a 151.57% increase from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from lines of credit for fiscal 2023 was $16.29M, a 63.80% decline from fiscal 2022.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from lines of credit for fiscal 2022 was $45.01M.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $30.93M 10-Q · filed 2026-08-06 | $34.20M derived: sum of 3 quarters · filed 2026-08-06 | $34.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $11.62M 10-Q · filed 2026-05-07 | $14.88M derived: sum of 2 quarters · filed 2026-05-07 | $14.88M derived: sum of 3 quarters · filed 2026-05-07 | $15.97M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $3.26M derived: sum of 2 quarters · filed 2026-03-10 | $4.35M derived: sum of 3 quarters · filed 2026-08-06 | $5.09M 10-K · filed 2026-03-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.09M derived: sum of 2 quarters · filed 2026-08-06 | $1.82M 10-Q · filed 2025-11-06 | $2.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.82M 10-Q · filed 2026-08-06 | $2.64M derived: sum of 3 quarters · filed 2026-08-06 | $8.60M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $735.00K 10-Q · filed 2026-05-07 | $1.55M derived: sum of 2 quarters · filed 2026-05-07 | $7.51M derived: sum of 3 quarters · filed 2026-05-07 | $36.92M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $819.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $6.78M derived: sum of 2 quarters · filed 2026-03-10 | $36.18M derived: sum of 3 quarters · filed 2026-03-10 | $40.99M 10-K · filed 2026-03-10 |
| 2024-09-30 | $5.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $35.36M derived: sum of 2 quarters · filed 2025-11-06 | $40.17M 10-Q · filed 2025-11-06 | $42.96M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $29.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $34.22M 10-Q · filed 2025-07-31 | $37.01M derived: sum of 3 quarters · filed 2025-07-31 | $37.01M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $4.81M 10-Q · filed 2025-05-06 | $7.60M derived: sum of 2 quarters · filed 2025-05-06 | $7.60M derived: sum of 3 quarters · filed 2025-05-06 | $20.67M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $2.79M derived: sum of 2 quarters · filed 2025-03-11 | $15.86M derived: sum of 3 quarters · filed 2025-03-11 | $16.29M 10-K · filed 2025-03-11 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $13.07M derived: sum of 2 quarters · filed 2024-11-07 | $13.50M 10-Q · filed 2024-11-07 | $26.97M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $13.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $13.50M 10-Q · filed 2024-08-08 | $26.97M derived: sum of 3 quarters · filed 2024-08-08 | $42.86M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $433.00K 10-Q · filed 2024-05-07 | $13.90M derived: sum of 2 quarters · filed 2024-05-07 | $29.79M derived: sum of 3 quarters · filed 2024-05-07 | $45.44M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $13.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $29.36M derived: sum of 2 quarters · filed 2024-03-12 | $45.01M derived: sum of 3 quarters · filed 2024-03-12 | $45.01M 10-K · filed 2024-03-12 |
| 2022-09-30 | $15.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $31.54M derived: sum of 2 quarters · filed 2023-11-07 | $31.54M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $15.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $15.64M 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$970.00K derived: sum of 2 quarters · filed 2020-11-09 | $547.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | -$970.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $547.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $1.52M 10-Q · filed 2020-05-11 | |||
| 2018-09-30 | $18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $45.51M derived: sum of 2 quarters · filed 2019-11-07 | $45.51M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $27.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $27.51M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-06-30 | -$1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.04M 10-Q · filed 2017-08-09 | $2.95M derived: sum of 3 quarters · filed 2018-05-10 | $8.03M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | $3.34M 10-Q · filed 2018-05-10 | $4.25M derived: sum of 2 quarters · filed 2018-05-10 | $9.34M derived: sum of 3 quarters · filed 2018-05-10 | $5.73M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $912.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $6.00M derived: sum of 2 quarters · filed 2017-03-14 | $2.39M derived: sum of 3 quarters · filed 2017-08-09 | $7.22M 10-K · filed 2017-03-14 |
| 2016-09-30 | $5.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.48M derived: sum of 2 quarters · filed 2017-08-09 | $6.31M 10-Q · filed 2016-11-09 | $7.81M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-06-30 | -$3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.22M 10-Q · filed 2017-08-09 | $2.72M derived: sum of 3 quarters · filed 2017-08-09 | $3.92M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $4.83M 10-Q · filed 2017-05-10 | $6.33M derived: sum of 2 quarters · filed 2017-05-10 | $7.53M derived: sum of 3 quarters · filed 2017-05-10 | $7.18M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $2.70M derived: sum of 2 quarters · filed 2017-03-14 | $2.35M derived: sum of 3 quarters · filed 2017-03-14 | $2.70M 10-K · filed 2017-03-14 |
| 2015-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $851.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.20M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$348.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $348.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-14 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |